BeStock  
Stocks › Biotechnology › CRSP

CRISPR Therapeutics CRSP

$39.10 +$0.17 (+0.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.50 +1.02%
Open$38.18
Prev close$38.93
Day range$38.15 – $40.17
Volume3.32M
Market cap$3.79B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.9x
CheapRich

Around its usual level · 53rd percentile, 5-year average -8.1x

Price / book2.5x
CheapRich

Around its usual level · 59th percentile, 5-year average 2.4x

#3463 of 5331 stocks by PB (1 = cheapest)

Price / sales162.8x
CheapRich

Above its usual level · 69th percentile, 5-year average 347.6x

#4990 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-50x-24x1x27xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$93.21
Price vs. fair value-58.1%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.49 – 2.41 59% (pricier than usual) #3463 of 5331 (1 = cheapest)
PE -8.93 -9.79 -8.05 53% (pricier than usual) –
PS 162.77 82.24 347.55 69% (pricier than usual) #4990 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CRSP.

Sign in to join the discussion.

Scroll to Top